Zero maker/taker fees apply to Standard accounts, while Plus and Premium use different terms. Margin mode is a separate choice, and non-USDC collateral introduces haircuts and liquidation exposure.
Reviewed 2026-10-14Version 1.0.0No live execution tests
What Matters
Separate fee tier from margin mode.
Provider-documentation review focused on perpetual trading. Not an exhaustive product inventory, live execution test, security audit or individual eligibility assessment.
Account fee tier, unified balances and multi-asset margin answer different questions. Check each independently before relying on a zero-fee or collateral headline.
DN Evidence Block
Claims, sources and practical consequences.
Provider-reported
Which accounts receive zero trading fees?
The fee guide lists zero maker/taker fees for Standard accounts. Plus and Premium accounts incur fees, and Premium discounts depend on staking.
Why it matters: Confirm the active fee tier. Do not extend Standard pricing to every account or confuse commission with total cost.
The multi-asset page lists ETH and XAUT collateral parameters, discounts their margin value and applies user/global caps. It directs readers to assetDetails for current enabled assets.
Why it matters: Collateral can lose value and be liquidated alongside perps. Static documentation is not a live inventory of available collateral capacity.
Do the documents clearly establish leveraged spot availability?
The multi-asset page includes broad spot examples but explicitly says non-USDC-funded USDC spot trading is excluded at launch.
Why it matters: This brief does not resolve that inconsistency or claim leveraged spot availability. Confirm the current product before relying on those examples.
Individual eligibility, signing authority, withdrawals and end-to-end execution were not tested.
Why it matters: Use the current terms and inspect permissions independently. This brief supplies no trading CTA.
Evidence boundary
No invented rates. No implied guarantees.
Current executable quotes and all-in holding costs
Independent fill, stop-loss and withdrawal reliability
Live signing permissions and revocation behaviour
Individual eligibility and current regional restrictions
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
Keep the evidence. Keep its limits.
The receipt preserves the provider sources and research gaps at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
Scope
Lighter perpetual trading (review scope)
Collateral scope
USDC balance treatment depends on mode; non-USDC margin has eligibility, haircut and cap conditions.
Initial documentation brief. Account-specific conditions and evidence limits are preserved in this version.
Review triggers: Changed official product, fee or margin documentation; A substantiated correction; The 14-day editorial review deadline. No automated provider surveillance runs for this brief.
How to use this research
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN may receive compensation through commercial links elsewhere on the site. This brief contains no trading CTA or payout-based ranking. A documentation review does not establish current operational status or user eligibility.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.